In March 2025, the company announced new designs for any direct-to-client featuring of its Wegovy weight loss drug. The company founded a new pharmacy, referred to as NovoCare, which would charge consumers $499 monthly for access to the drug, below 50 percent the price of the drug as a result of other pharmaceutical distribution networks.[fifty thr